Table 2.
Cell sources for ex vivo expansion cell-based therapy to treat Limbal Stem Cell Deficiency (LSCD).
Cell Sources | Application | References |
---|---|---|
Cultured Limbal Epithelial Cells (CLET) | Clinical application | [17,18,19,20,21] |
Cultured Oral Mucosal Epithelial Cells (COMET) | Clinical application | [30,31,33,34,35,36,37] |
Cultured Conjunctival Epithelial Cells | Clinical application | [38,39,40,41] |
Cultured Embryonic Stem Cells | Mice model | [42,43,44,45] |
Cultured Adult Epidermal Stem Cells | Goat model | [46,47,48] |
Cultured Bone-Marrow Derived Mesenchymal Stem Cells | Rat and rabbit models | [49,50,51,52,53] |
Cultured Adipose Derived Mesenchymal Stem Cells | In vitro model | [54,55] |
Cultured Orbital Fat Mesenchymal Progenitor Cells | Mice model; in vitro model | [56,57,58] |
Cultured Immature Dental Pulp Stem Cells | Rabbit model | [59,60] |
Cultured Hair Follicle-Derived Stem Cells | Mice model | [61,62] |
Cultured Umbilical Cord Stem Cells | Rabbit model | [63,64] |